Peramivir

🧮 Dose calculator

Influenza (flu) · Regimen source: FDA Rapivab · 2.1

• • Infuse over at least 15 min. FDA Rapivab · 2.1

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Rapivab · 8.1

  “Risk Summary Limited available data with RAPIVAB use in pregnant women are insufficient to determine a drug-associated risk of adverse developmental outcomes.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Rapivab · 8.2

  “Risk Summary There are no data on the presence of RAPIVAB in human milk, the effects on the breastfed infant, or the effects on milk production.”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Rapivab · 8.4

  “The safety and effectiveness of RAPIVAB for the treatment of influenza has been established in pediatric patients 6 months to 17 years of age.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Rapivab · 8.5

  “Clinical trials of RAPIVAB did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.